The metabolic syndrome predicts incident congestive heart failure: A 20-year follow-up study of elderly finns

被引:69
作者
Wang, Jianjun
Sarnola, Katriina
Ruotsalainen, Sanna
Moilanen, Leena
Lepisto, Paivi
Laakso, Markku
Kuusisto, Johanna [1 ]
机构
[1] Univ Kuopio, Dept Med, Cardiol Unit, Kuopio 70211, Finland
基金
芬兰科学院;
关键词
Metabolic syndrome; Definition; Congestive heart failure; Components; Predictor; RISK-FACTORS; CARDIOVASCULAR-DISEASE; OBESITY;
D O I
10.1016/j.atherosclerosis.2009.10.042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We investigated whether the metabolic syndrome (MetS) and its components defined by four different criteria including subjects with prevalent diabetes in their definitions were associated with congestive heart failure (CHF) independent of interim myocardial infarction (MI) and prevalent diabetes during a 20-year follow-up in an elderly population-based study. Methods and results: The MetS was defined according to the World Health Organization (WHO), the National Cholesterol Education Program (NCEP), the International Diabetes Federation (IDF), and the American Heart Association and the National Heart, Lung, and Blood Institute (AHA) criteria. The association of the MetS with incident CHF (303 cases) was investigated with Cox regression analyses in a 20-year follow-up study of 1032 Finns, aged 65-74 years at baseline. Among all subjects the MetS by all four criteria was significantly associated with a 1.45-1.74-fold risk for incident CHF after the adjustment for confounding factors. When subjects with interim MI during the follow-up and with prevalent diabetes were excluded, the MetS was significantly associated with a 1.37-1.87-fold risk for incident CHF after the adjustment for confounding factors. Of the single components of the MetS, the following were associated with incident CHF: impaired fasting glucose (IFG) [fasting plasma glucose (FPG)>= 6.1 mmol/l, Hazards ratio (HR) 1.46 or FPG >= 5.6 mmol/l, HR 1.62)]; raised blood pressure (BP) [(BP >= 140/90 mmHg or antihypertensive medications, HR 1.89); central obesity (waist circumference >= 94 cm in men or >= 80 cm in women, HR 1.49); (waist circumference >= 102cm in men or >= 88 cm in women, HR 1.48); obesity (body mass index >= 30 kg/m(2), HR 1.79); and low high-density lipoprotein cholesterol (<1.03 mmol/l in men or <1.29 mmol/l in women, HR 1.55). Conclusions: The MetS defined by four different criteria predicted CHF independent of interim MI and prevalent diabetes in elderly Finns, but not above and beyond the risk associated with one component of the MetS, hypertension. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:237 / 242
页数:6
相关论文
共 24 条
[1]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[2]   Novel metabolic risk factors for incident heart failure and their relationship with obesity [J].
Bahrami, Hossein ;
Bluemke, David A. ;
Kronmal, Richard ;
Bertoni, Alain G. ;
Lloyd-Jones, Donald M. ;
Shahar, Eyal ;
Szklo, Moyses ;
Lima, Joao A. C. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (18) :1775-1783
[3]  
Balkau B, 1999, DIABETIC MED, V16, P442
[4]   Metabolic syndrome and the risk of cardiovascular disease in older adults [J].
Butler, J ;
Rodondi, N ;
Zhu, YW ;
Figaro, K ;
Fazio, S ;
Vaughan, DE ;
Satterfield, S ;
Newman, AB ;
Goodpaster, B ;
Bauer, DC ;
Holvoet, P ;
Harris, TB ;
de Rekeneire, N ;
Rubin, S ;
Ding, JZ ;
Kritchevsky, SB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) :1595-1602
[5]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]  
Einhorn Daniel, 2003, Endocr Pract, V9, P237
[7]   RISK-FACTORS FOR HEART-FAILURE IN THE GENERAL-POPULATION - THE STUDY OF MEN BORN IN 1913 [J].
ERIKSSON, H ;
SVARDSUDD, K ;
LARSSON, B ;
OHLSON, LO ;
TIBBLIN, G ;
WELIN, L ;
WILHELMSEN, L .
EUROPEAN HEART JOURNAL, 1989, 10 (07) :647-656
[8]   Coronary artery disease as the cause of incident heart failure in the population [J].
Fox, KF ;
Cowie, MR ;
Wood, DA ;
Coats, AJS ;
Gibbs, JSR ;
Underwood, SR ;
Turner, RM ;
Poole-Wilson, PA ;
Davies, SW ;
Sutton, GC .
EUROPEAN HEART JOURNAL, 2001, 22 (03) :228-236
[9]   Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations [J].
Giles, TD ;
Sander, GE .
CARDIOLOGY CLINICS, 2004, 22 (04) :553-+
[10]   Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [J].
Grundy, SM ;
Cleeman, JI ;
Daniels, SR ;
Donato, KA ;
Eckel, RH ;
Franklin, BA ;
Gordon, DJ ;
Krauss, RM ;
Savage, PJ ;
Smith, SC ;
Spertus, JA ;
Costa, F .
CIRCULATION, 2005, 112 (17) :2735-2752